Gallego Gisselle, Taylor Susan J, McNeill Paul, Brien Jo-anne E
Centre for Health Economics Research and Evaluation (CHERE), University Technology Sydney, Sydney, NSW, Australia.
Health Expect. 2007 Sep;10(3):224-35. doi: 10.1111/j.1369-7625.2007.00439.x.
To gather information about views of members of the general public about access to High Cost Medications (HCMs) in public hospitals.
A structured questionnaire was administered to members of the general public. Individuals were approached in train stations, shopping centres and different venues in the Sydney metropolitan area. People were eligible to answer the survey if they were: over 18 years of age, Australian permanent residents and able to complete the questionnaire in English.
Two hundred people completed the survey. Of these 56% were females, 47% were married, 84% spoke English at home, 88% were working either full-time or part-time, 61% had a university degree, 27% had a household annual income greater than 100,000 dollars and 68% had private health insurance. Participants considered factors such as treatment outcomes, quality of life and current health status when determining who should have access to HCMs. Participants wanted resources to be allocated to provide the 'greatest benefit to the greatest number of people'. Almost half the respondents did not want direct involvement in decision-making, however, 38% did.
The results offered support for indirect involvement through the development of a process to involve community members in discussion on policy on the provision of treatment and services within health-care institutions and specifically, to seek the views of members of the public on the provision of HCMs and expensive services within public hospitals.
收集公众对公立医院获取高成本药物(HCMs)的看法。
对公众进行结构化问卷调查。在悉尼都会区的火车站、购物中心和不同场所接触个人。如果他们符合以下条件,则有资格回答调查:年龄超过18岁、澳大利亚永久居民且能够用英语完成问卷。
200人完成了调查。其中56%为女性,47%已婚,84%在家说英语,88%全职或兼职工作,61%拥有大学学位,27%家庭年收入超过10万美元,68%拥有私人医疗保险。参与者在确定谁应能获取高成本药物时会考虑治疗结果、生活质量和当前健康状况等因素。参与者希望资源分配能“为最多的人带来最大的益处”。近一半的受访者不希望直接参与决策,然而,38%的受访者希望。
结果支持通过制定一个让社区成员参与医疗机构内治疗和服务提供政策讨论的流程来进行间接参与,特别是就公立医院高成本药物和昂贵服务的提供征求公众意见。